AstraZeneca

AstraZeneca gives itself top marks for R&D productivity makeover — but the jury is still out
Endpoints
Fri, 01/19/18 - 11:34 am
R&D
AstraZeneca
In a pioneering first, AstraZeneca scores FDA OK to use its PARP against breast cancer
Endpoints
Fri, 01/12/18 - 10:39 am
AstraZeneca
PARP inhibitors
FDA
Lynparza
metastatic breast cancer
2018 Healthcare And Biotech Outlook
Seeking Alpha
Sun, 01/7/18 - 12:41 pm
AbbVie
Abbott Labs
Amgen
Allergan
AstraZeneca
Gilead Sciences
Bristol-Myers Squibb
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Fierce Pharma
Fri, 01/5/18 - 10:28 am
China
Opdivo
Repatha
Lynparza
drug approvals
Bristol-Myers Squibb
Amgen
AstraZeneca
Eli Lilly
Gilead Sciences
AstraZeneca sells US rights to 4 non-core drugs
Biopharma Dive
Wed, 01/3/18 - 11:07 am
AstraZeneca
ANI Pharmaceuticals
Atacand
Atacand HCT
Casodex
Arimidex
Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China this year, new report predicts
Endpoints
Tue, 01/2/18 - 11:44 am
Bristol-Myers Squibb
AstraZeneca
Opdivo
Lynparza
China
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
FDA Pulls Boxed Warnings on Asthma Risks on Some Inhalers
RAPS.org
Thu, 12/21/17 - 10:35 pm
FDA
warnings
asthma
inhalers
ICS/LABA inhalers
GSK
Advair Diskus
AstraZeneca
Symbicort
Merck
Dulera
AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA
Yahoo/Zacks.com
Tue, 12/19/17 - 10:24 am
AstraZeneca
Tagrisso
FDA
labeling
non-small cell lung cancer
Leif Johansson, AstraZeneca’s chairman, on possible Brexit aftermaths
GoinPharma
Thu, 12/14/17 - 09:23 pm
AstraZeneca
Brexit
Leif Johansson
GlaxoSmithKline, now vying with AstraZeneca, scores brand-new market for Nucala
Fierce Pharma
Wed, 12/13/17 - 11:07 am
GSK
AstraZeneca
Nucala
eosinophilic granulomatosis with polyangiitis
In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib
Endpoints
Fri, 12/8/17 - 11:46 am
Pfizer
AstraZeneca
talazoparib
advanced breast cancer
Lynparza
PARP inhibitors
Most Damaging Clinical Trial Failure: AstraZeneca's MYSTIC
BioPharma Dive
Mon, 12/4/17 - 09:42 pm
clinical trials
AstraZeneca
Mystic
Imfinzi
non-small cell lung cancer
AstraZeneca teams with China-owned fund to launch a new biopharma drug development company
Endpoints
Mon, 11/27/17 - 10:13 am
AstraZeneca
China
Dizal Pharmaceutical
3 Companies Competing to Gain Lead in Ovarian Cancer Market
Yahoo/Zacks.com
Sat, 11/25/17 - 12:35 pm
ovarian cancer
AstraZeneca
Merck
Lynparza
Rubraca
Clovis Oncology
Zejula
Tesaro
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Nektar
AstraZeneca
Movantik
Onzeald
UCB Pharma
Cimzia
Amgen
Neulasta
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Fierce Pharma
Fri, 11/24/17 - 09:23 am
JNJ
Eli Lilly
AstraZeneca
Boehringer Ingelheim
diabetes
Invokana
Farxiga
Jardiance
AstraZeneca touts Tagrisso's CNS benefit
BioPharma Dive
Tue, 11/21/17 - 09:45 am
Tagrisso
AstraZeneca
non-small cell lung cancer
CNS metastases
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
Fierce Pharma
Mon, 11/20/17 - 11:12 am
GSK
Nucala
AstraZeneca
Fasenra
eosinophilic asthma
asthma
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma

Pages